Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. GCP Research

Verified

Basic Information

Site Overview

Source: Human-provided.

GCP Research (Global Clinical Professionals) is a privately owned clinical research organization specializing in Phase I–IV clinical trials for pharmaceutical, biotechnology, medical device, and government-sponsored studies. Headquartered in Florida with research operations in St. Petersburg and Ocala, the organization also maintains a network of investigators and research sites across the United States, Central America, and South America. GCP Research has extensive experience in therapeutic areas including dermatology, general medicine, vaccines, women's health, pain management, pharmacokinetics/pharmacodynamics (PK/PD), renal and hepatic impairment, and imaging studies. The organization provides comprehensive clinical trial services, including protocol feasibility, site management, regulatory support, patient recruitment, and project management, supported by experienced investigators, clinical research coordinators, regulatory specialists, and quality assurance professionals. GCP…

Source: Trial-derived.
41Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
12Active Trials
Source: Trial-derived.
25Completed Trials
Source: Trial-derived.
35Unique Conditions
Source: Trial-derived.
25Unique Sponsors

Conditions

Source: Trial-derived. Atopic Dermatitis (6)Source: Trial-derived. COVID-19 (4)Source: Trial-derived. Celiac Disease (3)Source: Trial-derived. Dermatitis Atopic (3)Source: Trial-derived. Plaque Psoriasis (3)Source: Trial-derived. Hepatic Impairment (2)Source: Trial-derived. Acute Gastroenteritis (1)Source: Trial-derived. Asthma (1)

Sponsors

Source: Trial-derived. Pfizer (9)Source: Trial-derived. Sanofi (4)Source: Trial-derived. AbbVie (3)Source: Trial-derived. Shionogi (3)Source: Trial-derived. Vertex Pharmaceuticals Incorporated (3)Source: Trial-derived. DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company (2)Source: Trial-derived. Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA (2)Source: Trial-derived. ModernaTX, Inc. (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic participant diary (ePRO) system
Source: AI-inferred. Electronic patient-reported outcome (ePRO) device system
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Virus neutralisation antibody assay